Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
Trial:
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Universitatsklinikum Essen, West Germany Cancer Center

Hufelandstr. 55     
Essen , 45122
Germany

 

Principal Investigator:
Sebastian Bauer
Contact:
Sebastian Bauer
Activation Status of this Site:
Active
Notes about this Site:
Universitatsklinikum Essen, West Germany Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.